• We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

Social Media

See the latest interactions from our social media


PRA opens new office in #Singapore expanding its Asia Pacific #clinicalresearch capabilities. Since ...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences Expands Operations in Singapore

17 November 2015, Raleigh, NC – PRA Health Sciences (PRA) (NASDAQ: PRAH) is pleased to announce that it is relocating to a new office in Singapore to support its expanded operations in the...

PRA Health Sciences, inc. Reports third quarter 2015 results and provides updated 2015 guidance

• $345.1 million of service revenue in the third quarter; 12% constant currency growth compared to the third quarter of 2014
• $66.6 million of Adjusted EBITDA in the third quarter; 42%...

PRA Health Sciences Opens New Bioanalytical Laboratory in the Netherlands

26 October 2015 Raleigh, NC – PRA Health Sciences (PRA) (NASDQ: PRAH) is pleased to announce the opening of its brand new, state-of-the-art Bioanalytical Laboratory in Assen, the Netherlands....

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.


PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.


Find out what's happening next on PRA's event schedule

December 1 - December 2

After establishing itself as the leading Pharmacovigilance conference across Europe, the event is returning astoundingly for its 11th Year with an even stronger presence from both the pharmaceutical and regulatory boards. With a mixture of Head of PV, Regulatory and compliance experts composing the majority of the line-up, this event promises to deliver you cutting […]

December 5 - December 8

The American Society of Hematology (ASH) invites you to save the date for the 57th ASH Annual Meeting in Orlando, FL. As the premier event in malignant and non-malignant hematology, this meeting will provide attendees with an invaluable educational experience.

Read More >